Filing Details
- Accession Number:
- 0001082038-19-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-15 20:37:32
- Reporting Period:
- 2019-03-13
- Accepted Time:
- 2019-03-15 20:37:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082038 | Durect Corp | DRRX | Pharmaceutical Preparations (2834) | 943297098 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1114914 | S Jon Saxe | 10260 Bubb Road Cupertino CA 95014 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-13 | 900 | $0.82 | 42,200 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 100 | $0.82 | 42,300 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 100 | $0.82 | 42,400 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 800 | $0.82 | 43,200 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 200 | $0.82 | 43,400 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 100 | $0.82 | 43,500 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 100 | $0.82 | 43,600 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 600 | $0.82 | 44,200 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 200 | $0.82 | 44,400 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 200 | $0.82 | 44,600 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 300 | $0.82 | 44,900 | No | 4 | P | Indirect | by Trust |
| Common Stock | Acquisiton | 2019-03-13 | 100 | $0.82 | 45,000 | No | 4 | P | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
| No | 4 | P | Indirect | by Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 27,810 | Direct |
Footnotes
- Held by Jon S. Saxe and Myrna G. Marshall 1997 Trust.
Billionaire Hedge Funds
